← Eichor
Study identifier: NCT06752486 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Assessment of Safety and Efficacy of Gabapentin After Surface Ablation, a Case Control Experimental Study

Condition: Pain After Photorefractive Keratectomy · VAS Will be Used to Assess Pain Postoperative  ·  Sponsor: Research Institute of Ophthalmology, Egypt

PhasePhase 1
Planned participants64
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersNo

About this study

The current study aims at assessing the efficacy and safety of oral Gabapentin alone versus Diclofenac Potassium drugs for postoperative analgesia in patients undergoing surface ablation.

This description comes directly from the study's public registry record.

Talk to the study team

Dina Moustafa M Ali, MD  ·  01113981021  ·  dina.moustafa.ali@gmail.com

Mohamed Tarek Ahmed El- Naggar, MD- FRCS  ·  01222158593  ·  drtarekelnaggar@hotmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Research Institute of OphthalmolgyGiza, EgyptRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06752486